Quidels QuickVue® Influenza A+B Test Now Available in the United States
SAN DIEGO -- Quidel Corporation today announced that its new QuickVue Influenza test A+B has become available in the United States. The new, CLIA-waived QuickVue Influenza A+B test provides information to aid in the differential diagnosis of acute influenza type A or B. The test provides physicians with a fast, accurate, easy-to-use method for aiding in the differential diagnosis of acute influenza type A or B. Using a nasal swab or nasal/wash aspirate, the test is designed to deliver results in 10 minutes or less and require only 30 seconds of hands-on time. Test kits can be stored at room temperature and have a 24-month shelf life from manufacture date.
Source: Quidel Corporation
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.
